Morgan Stanley assumed coverage of Palantir (PLTR) with an Underweight rating and $60 price target Palantir’s commercial traction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback